Recent studies have pointed to an important role of microRNAs carcinogenesis. In fact, 28 several microRNAs have been described as aberrantly expressed in CRC tissues and in 29 the serum of patients. More specifically, microRNAs with dual roles in both cancer and 30 stem cell survival represent a potential source of novel molecular targets in CRC due to 31 their described functions in normal and deregulated proliferation. However, the 32 functional outcomes of microRNA aberrant expression still need to be explored at the 33 cellular level. Here, we aimed to investigate the effects of microRNAs involved in the 34 control of pluripotency of stem cells in the proliferation and cell death of a colorectal 35 cancer cell line. 36
Abstract

26
Background: Colorectal cancer (CRC) is still a leading cause of death worldwide. 27
Recent studies have pointed to an important role of microRNAs carcinogenesis. In fact, 28 several microRNAs have been described as aberrantly expressed in CRC tissues and in 29 the serum of patients. More specifically, microRNAs with dual roles in both cancer and 30 stem cell survival represent a potential source of novel molecular targets in CRC due to 31 their described functions in normal and deregulated proliferation. However, the 32 functional outcomes of microRNA aberrant expression still need to be explored at the 33 cellular level. Here, we aimed to investigate the effects of microRNAs involved in the 34 control of pluripotency of stem cells in the proliferation and cell death of a colorectal 35 cancer cell line. 36
Methods:
We performed transfection of 31 microRNA mimics in HCT116 CRC cells. 37
Cell proliferation and cell death were measured after 4 days of treatment using 38 fluorescence staining in a high content screening platform. Total number of live and 39 dead cells were automatically counted and analyzed. To reveal mRNA targets, we used 40 an oligonucleotide microarray. Functional classification of targets was done using 41 DAVID tool. Gene expression of potential mRNA targets was performed by qPCR. 42
Results: Twenty microRNAs altered the proliferation of HCT116 cells in comparison to 43
control. Three microRNAs significantly repressed cell proliferation and induced cell 44 death simultaneously (miR-22-3p, miR-24-3p, and miR-101-3p) . Interestingly, all anti-45 proliferative microRNAs in our study had been previously described as poorly 46 expressed in the CRC samples and were implicated in the disease. Microarray analysis 47 prognosis of CRC [3] [4] [5] . 70 miRNAs are usually encoded in the human genome as clusters. After nuclear 71 processing, these molecules are exported to the cytoplasm and loaded into RNA-72 induced silencing complexes (RISC), directing them against binding sites in the 3'-UTR 73 region of target mRNAs, based on the degree of complementarity. While a perfect 74 match leads to mRNA cleavage, miRNAs with partial complementarity lead to 75 translation blockade and/or mRNA degradation through multiple mechanisms [6] . In 76 either case, miRNAs predominantly act to decrease target mRNA levels [7] . Since a 77 miRNA:mRNA perfect match is not required for miRNA silencing of its targets, one 78 miRNA can affect the expression of hundreds of target transcripts. Hence, deregulation 79 of a single miRNA can lead to global alterations in gene expression in a given cell [8] . 80
Aberrant expression of miRNAs contributes to tumorigenesis mainly by two 81 mechanisms: repression of tumor suppressor genes or loss of repression of oncogenes 82 [9] . In the first case, miRNAs become overexpressed and downregulate the expression 83 of tumor suppressor genes; in the latter case, miRNAs become downregulated 84 themselves while their oncogene targets are overexpressed due to reduced post-85 transcriptional silencing. This abnormal miRNA profile can facilitate proliferation and 86 survival of tumor cells in malignancies such as CRC [10] . 87 miRNAs controlling pluripotency of embryonic stem cells have been associated with 88 tumorigenesis in diverse cancers, including CRC [11] [12] [13] . In fact, cancer cells and 89 pluripotent stem cells share the ability to proliferate rapidly and virtually indefinitely [14] . 90 Strikingly, reprograming of somatic cells into induced pluripotent stem cells share many 91 similarities with the process of malignant transformation [15] . Therefore, miRNAs 92 controlling stemness and differentiation of stem cells have potential to be used as 93 targets for the study of uncontrolled proliferation in cancer. However, this has not yet 94 been tested in the context of CRC, and functional data on the effects of these miRNAs 95 in the survival of CRC cells is still lacking. 96
We hypothesized that miRNAs involved in the control of pluripotency and differentiation 97 of stem cells can alter the proliferation and survival of CRC cells. With that in mind, we 98 have selected a panel of 31 miRNAs that have their expression modulated during the 99 differentiation of embryonic stem cells [16] . We then set out to identify the effects of 100 these miRNAs on the proliferation and cell death in a human cellular model of CRC. 101
Importantly, most of the miRNAs in this panel have been described to be differentially 102 expressed in CRC (Table 1) Predicted targets of miR-101-3p were obtained from the TargetScan database [18] . In 164 order to carry a pathway enrichment analysis, we used the whole set of predicted 165 targets that were also downregulated by miR-101-3p in our microarray analysis. This set 166 of transcripts were analyzed using the Database for Annotation, Visualization and 167
Integrated Discovery (DAVID) [19] , restricting the analysis to pathway data from the 168 Kyoto Encyclopedia of Genes and Genomes (KEGG) [20] . (Table 1) . Additionally, the functional outcomes of up-and 177 downregulation of specific miRNAs in colorectal cancer cells remain to be fully 178
evaluated. 179
To investigate the effects of miRNAs on the proliferation and survival of CRC cells, we 180 performed a focused screen in HCT116 cell line. Cells were transfected with 31 181 synthetic miRNA duplexes mimics and cultured for 4 days. These so called pre-miR 182 molecules are small, double-stranded RNA molecules designed to mimic endogenous 183 mature miRNAs. Chemical modifications induce loading of the correct strand into RISC 184 Table 1 Eight miRNAs described as upregulated in CRC tissues or serum samples induced 199 significant increase in cell proliferation (miR-21-5p, -23a-3p, -27a-3p, -92a-3p, -181d-5p, 200 -222-3p, -372-3p, and -373-3p) , whereas only one CRC-upregulated miRNA inhibited 201 proliferation (miR-24-3p). Cancer and pluripotency related miRNAs belonging to clusters 202 miR-106a~363, miR-17~92 and miR-302 induced significant increase in proliferation. 203
Notably, mimics of miR-22-3p, miR-24-3p, and miR-101-3p, all described as CRC-204 downregulated miRNAs, simultaneously reduced cell proliferation and induced cell 205 death, significantly, when compared to control. We decided to focus on miR-101-3p for 206 further experiments due to described involvement of this miRNA in CRC. Repressive Complex 2 Subunit (EZH2), which is a predicted target of miR-101-3p that 268 has been linked to oncogenesis in CRC [22, 23] . Analysis of canonical Wnt pathway 269 genes reveled upregulation of ß-catenin mRNA (CTNNB1) whereas Glycogen Synthase 270
Kinase 3 Beta (GSK3B) and Adenomatous Polyposis Coli (APC) remained unaltered, in 271 spite of both GSK3B and APC being predicted targets of miR-101-3p. 272
We found that Myeloid cell leukemia-1 (MCL1), a member of the BCL-2 family of tumor 273 suppressors and a predicted target of miR-101-3p, was downregulated in our 274 microarray data. MCL1 gene encoded three isoforms: one long, anti-apoptotic MCL-1L, 275
and two shorter pro-apoptotic MCL-1S and MCL-1ES [24] . Downregulation of MCL1 276 mRNA observed in the microarray was confirmed by qPCR. Interestingly, only the anti-277 apoptotic isoform of MCL-1 was downregulated by miR-101-3p (MCL-1L, Figure 3a) . 278
Additional apoptosis-related genes that closely interact with MCL-1 were also 279 downregulated by miR-101-3p in our microarray data (Figure 3b) . 280 281 Discussion 282
283
In the present study, we evaluated the effects of 31 miRNAs on the proliferation and 284 survival of a colorectal cancer cell line. Twenty miRNA mimics significantly altered 285 HCT116 total cell numbers compared to control. Mimics of miR-22-3p, miR-24-3p, and 286 miR-101-3p significantly reduced cell proliferation whilst inducing significant cell death 287 when compared to control. 288
Differential expression of miRNAs is a common feature of many malignancies. 289
Upregulation of oncomiRs and, conversely, downregulation of tumor suppressor 290 miRNAs is believed to play a role in the proliferation and survival of cancer cells [9, 25] . 291
Perhaps not surprisingly, around 30-50% of miRNAs are located at instable, cancer-292 associated genomic regions, and fragile sites [26, 27] , which contributes to their 293 aberrant expression profiles. miRNAs controlling pluripotency and differentiation of stem 294 cells have been shown to be involved in tumorigenic processes and cancer stem cell 295 derivation [28] . 296
The panel of miRNAs tested in the present study represent miRNAs downregulated or 297 upregulated during the differentiation of embryonic stem cells [16] . It is hypothesized 298 that during the differentiation process downregulated miRNAs are involved in the 299 maintenance of stemness properties, whereas miRNAs upregulated are involved in the 300 induction of differentiation. More importantly, the miRNAs tested also represent the 301 most frequently reported as differentially expressed miRNAs in CRC (Table 1) . 302
Zhu and colleagues identified 38 miRNAs differentially expressed in tumor tissues of 303 CRC patients [29] . Among the 30 miRNAs found upregulated in that study, miR-21-5p, 304 miR-20b-5p, miR-106a-5p, miR-92a-3p and miR-17-3p were also included in our study 305 and, except for miR-18b, they all stimulated cell proliferation of HCT116 cells in our 306 screening, albeit only significantly for miR-21-5p and miR-92-3p. On the other hand, 307 miRNAs that significantly reduced cell proliferation and induced cell death in our study 308 several miRNAs tested in our screening [33] . Among the concordantly upregulated 311 miRNAs in serum and CRC biopsies in that study, miR-92-3p and miR-222-3p were 312 also tested in our screening and induced significant increase in proliferation of HCT116 313 cells. 314 miRNAs can be expressed from polycistronic clusters wherein several miRNAs stem 315 from the same primary transcript [34] . In this study, we investigated miRNAs belonging 316 to cluster miR-17~92 (miR-17-3p, -18a-5p, -19a-3p, -19b-3p, -20a-5p, -92a-3p), cluster 317 miR-106a~363 (miR-18b-5p, -20b-5p, -106a-5p, -363-3p) and cluster miR-302 (miR-318 302a-3p, -302a-5p, -302b-3p, -302b-5p, -302c-3p, -302d-3p) . These clusters are 319 abundantly expressed in pluripotent stem cells and are involved in stemness 320 maintenance [35] while also being associated with deregulated proliferation and 321 malignancies [36, 37] . Overall, the cluster miR-17~92 induced proliferation in our 322 screening. This cluster is located at chromosome 13q31, one of the regions associated 323 with CRC progression. Previous work has demonstrated that gain of the region 324 containing this cluster leads to increased expression of the corresponding miRNAs in 325 CRC tumor samples [37] . Taken together, the proliferation profile observed in our study 326 points to a proliferative advantage for augmented expression of cluster miR-17~92 in 327
CRC. 328
The pluripotency-associated cluster miR-302 induced marked proliferation of HCT116 329 cells in our study. Overexpression of this cluster is sufficient to reprogram somatic cells 330 to pluripotency [38] . However, it has been suggested that although these miRNAs 331 activate a pluripotency program in the target cells, they do so while also protecting cells 332 from malignant transformation [39] . Previous work corroborating this idea has 333 suggested that overexpression of miR-302 cluster actually can rescue malignant cells 334 by reducing their proliferative profile and invasiveness [40] . A contrasting study 335
indicates that overexpression of miR-302 cluster in cancer cells actually leads to a more 336 invasive and undifferentiated cancer state [28] . Although our data supports the latter 337 hypothesis, more studies in CRC models will be needed to address the context-338 dependent functions of miR-302 cluster in this malignancy. speculate that miR-101-3p may interfere with the non-canonical Wnt pathway, given 392 that genes downregulated in our microarray most likely reflect this hypothesis (CXXC4, 393 CAMK2G, FZD4, FZD6, NLK, PLCB1, RAC1) . For instance, expression of Nemo-like 394 kinase (NLK) has been demonstrated to be necessary for cell cycle progression in CRC 395 in vitro [66] . 396
In addition to inhibiting cell proliferation, miR-101-3p also remarkably induced cell death 397 in treated cells. Several pathways have been implicated in the induction of apoptosis by 398 miR-101-3p in different cancer cell models [67] [68] [69] . Microarray analysis provided some 399 clues on what genes can be modulated in order to warrant such effect on cell survival. 400 MCL-1 is a member of the BCL-2 superfamily of apoptosis regulators, and it is one of 401 the most frequently amplified genes in cancers [70] . MCL-1 gene encodes three 402 isoforms: the long, anti-apoptotic MCL-1L, and two shorter pro-apoptotic MCL-1S and 403 MCL-1ES [24] . MCL-1 amplification accounts for resistance to the BCL-2/BCL-xL 404 inhibitor ABT-737 (Chen et al., 2007 , Keuling et al., 2009 , van Delft et al., 2006 . MCL-1 405 associates with mitochondrial membrane-associated proteins, Bak and Bax, preventing 406 them from heterodimerizing with apoptotic members of the BCL-2 family to promote 407 apoptosis cascade [71] . More strikingly, a recent study has demonstrated that 408 degradation of MCL-1 is necessary for effective therapeutics against CRC [72] . 409
Similarly, inhibition of MCL-1 by miR-101-3p has been implicated in the apoptosis-410 inducing effect of anti-cancer drug doxorubicin in hepatocellular carcinoma [73] . A 411 similar inhibitory mechanism between miR-101-3p and MCL-1 has been reported for 412 endometrial cancer as well [46] . The specific inhibition of only the anti-apoptotic MCL-1 413 isoform in our study highlights a novel mechanism by which miR-101-3p can induce 414 apoptosis and cell death in our screening, and points to a possible therapeutic target for 415 oligonucleotide-based therapies. 416
Overall, the cell proliferation profile observed in our model of CRC points to an 417 interesting tendency: miRNAs overexpressed in CRC augment cell proliferation and, 418 conversely, miRNAs poorly expressed in CRC reduce cell proliferation and survival. 
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